LYRA

LYRA

USD

Lyra Therapeutics Inc. Common Stock

$12.830-0.500 (-3.751%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$13.330

最高

$13.502

最低

$11.670

交易量

0.20M

公司基本面

市值

17.0M

行業

生物科技

國家

United States

交易統計

平均交易量

0.65M

交易所

NCM

貨幣

USD

52週範圍

最低 $3.81當前 $12.830最高 $37.5

相關新聞

Analyst Upgrades

HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16

HC Wainwright & Co. analyst Matthew Caufield maintains Lyra Therapeutics with a Neutral and raises the price target from $2 to $16.

查看更多
HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16
GlobeNewswire

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078)ENLIGHTEN 2 trial also showed

查看更多
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)